Information available to help campaigning across Europe

Europa Uomo has published a presentation of its EUPROMS study findings in 17 different languages, to help patient groups around Europe communicate key messages about quality of life after treatment.

EUPROMS (the Europa Uomo Patient Reported Outcome Study) is the first ever prostate cancer quality of life survey conducted by patients for patients, based on nearly 3,000 responses to an online questionnaire by men with prostate cancer across Europe.

Its findings cover general quality of life, mental health, sexual function, incontinence, discomfort, tiredness and insomnia – and these are all covered in a downloadable PowerPoint presentation. It is now available to download from the Europa Uomo website in 17 languages: Czech, Danish, Dutch, English, Finnish, French, German, Greek, Hungarian, Italian, Latvian, Lithuanian, Norwegian, Polish, Portuguese, Spanish and Swedish.

The findings provide information that may help patients and their doctors make decisions about treatments and help in campaigning for early diagnosis of prostate cancer and promoting approaches such as active surveillance.

“We very much hope that our member organisations and men with prostate cancer will use this new presentation to spread important messages about the importance of early diagnosis,” says Europa Uomo Chairman André Deschamps. “It’s very clear from the data we present here that the more advanced the prostate cancer at diagnosis, the worse the effects of treatment on quality of life.”